TITLE:
Research Progress on Inflammation-Related Biomarkers for Prognosis after Emergency PCI in STEMI Patients
AUTHORS:
Zhengkui Qin, Xiuge Tang
KEYWORDS:
Acute ST-Segment Elevation Myocardial Infarction (STEMI), Percutaneous Coronary Intervention (PCI), Inflammatory Biomarkers, Disease Prognosis, Major Adverse Cardiovascular Events (MACE)
JOURNAL NAME:
World Journal of Cardiovascular Diseases,
Vol.16 No.6,
June
22,
2026
ABSTRACT: Although emergency percutaneous coronary intervention (PCI) can rapidly restore myocardial perfusion in patients with acute ST-segment elevation myocardial infarction (STEMI), these patients still face a relatively high risk of major adverse cardiovascular events (MACE) after the procedure. The inflammatory response plays a central role in myocardial injury, ventricular remodeling, and thrombosis following STEMI. This article reviews the predictive value of inflammation-related biomarkers—including C-reactive protein, fibrinogen, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, systemic immune-inflammation index, systemic inflammatory response index, and red cell distribution width—for prognosis after emergency PCI in STEMI patients, aiming to provide a reference for clinical risk assessment and stratification.